2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Stomach Neoplasms
19
Colorectal Neoplasms
16
Esophageal Neoplasms
13
Barrett Esophagus
8
Colonic Neoplasms
7
Rectal Neoplasms
6
Gastrointestinal Neoplasms
6
Colonic Polyps
6
Neoplasms
3
Duodenal Neoplasms
3
Adenoma, Villous
3
Adenocarcinoma Of Esophagus
3
Precancerous Conditions
2
Lung Neoplasms
2
Hemorrhage
2
Gastric GIST
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Adenoma
2
Tobacco Use Disorder
1
Submucosal Tumor of Stomach
1
Small Size Gastrointestinal Stromal Tumors
1
Small Cell Lung Carcinoma
1
Rectal Neuroendocrine Tumors
1
Predictive Cancer Model
1
Polyps
1
Polyposis, Gastric
1
Pituitary Neoplasms
1
Personal Satisfaction
1
Pathological Conditions, Anatomical
1
Interventions
Etoposide
155
Carboplatin
144
Cisplatin
105
Topotecan
76
durvalumab
52
atezolizumab
50
Irinotecan
45
pembrolizumab
38
Paclitaxel
34
Nivolumab
33
Radiotherapy
31
PM 01183
24
Drug Therapy
24
anlotinib
23
Gemcitabine
21
apatinib
19
Ipilimumab
18
Docetaxel
17
Temozolomide
16
Platinum
16
Radiosurgery
15
Pemetrexed
14
toripalimab
13
tislelizumab
13
olaparib
13
Magnetic Resonance Spectroscopy
13
Bevacizumab
13
rovalpituzumab tesirine
11
amrubicin
11
Specimen Handling
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Endoscopic Mucosal Resection
×
Clear all
NCT00751660
2012-03-09
Pan Can
British Columbia Cancer Agency
Phase NA
Unknown
2,504 enrolled